198 related articles for article (PubMed ID: 19271093)
1. The facilitatory effect of duloxetine combined with pelvic floor muscle training on the excitability of urethral sphincter motor neurons.
Mehnert U; Boy S; Widmer-Simitovic S; Reitz A; Schurch B
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Jun; 20(6):659-66. PubMed ID: 19271093
[TBL] [Abstract][Full Text] [Related]
2. Facilitatory neuromodulative effect of duloxetine on pudendal motor neurons controlling the urethral pressure: a functional urodynamic study in healthy women.
Boy S; Reitz A; Wirth B; Knapp PA; Braun PM; Haferkamp A; Schurch B
Eur Urol; 2006 Jul; 50(1):119-25. PubMed ID: 16455184
[TBL] [Abstract][Full Text] [Related]
3. Initial management of stress urinary incontinence: pelvic floor muscle training and duloxetine.
Freeman RM
BJOG; 2006 May; 113 Suppl 1():10-6. PubMed ID: 16529564
[TBL] [Abstract][Full Text] [Related]
4. The effects of duloxetine on urethral function and sphincter morphology.
Athanasiou S; Chaliha C; Digesu GA; Sotiropoulou M; Georgoulias N; Khullar V; Antsaklis A
Int Urogynecol J Pelvic Floor Dysfunct; 2007 Jul; 18(7):763-7. PubMed ID: 17061027
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence.
Ghoniem GM; Van Leeuwen JS; Elser DM; Freeman RM; Zhao YD; Yalcin I; Bump RC;
J Urol; 2005 May; 173(5):1647-53. PubMed ID: 15821528
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
Thor KB
Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
[TBL] [Abstract][Full Text] [Related]
7. The effect of duloxetine on urethral sphincter morphology.
Duckett J; Patil A; Aggarwal I
Ultrasound Obstet Gynecol; 2008 Feb; 31(2):206-9. PubMed ID: 18254135
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine: in stress urinary incontinence.
McCormack PL; Keating GM
Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
[TBL] [Abstract][Full Text] [Related]
9. What do we know about duloxetine's mode of action? Evidence from animals to humans.
Schuessler B
BJOG; 2006 May; 113 Suppl 1():5-9. PubMed ID: 16529563
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training.
Brunenberg DE; Joore MA; Veraart CP; Berghmans BC; van der Vaart CH; Severens JL
Clin Ther; 2006 Apr; 28(4):604-18. PubMed ID: 16750472
[TBL] [Abstract][Full Text] [Related]
11. Effect of Duloxetine on Urethral Resting Pressure and on Sphincter Contractility in Response to Coughing and Magnetic Stimulation in Healthy Women.
Yono M; Otani M; Ito K; Inoue Y; Furukawa K; Hori M; Tsuji S; Tanaka T; Sakata Y; Irie S
Low Urin Tract Symptoms; 2015 May; 7(2):93-8. PubMed ID: 26663688
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
Jost W; Marsalek P
Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
[TBL] [Abstract][Full Text] [Related]
13. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
[TBL] [Abstract][Full Text] [Related]
14. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Ayeleke RO; Hay-Smith EJ; Omar MI
Cochrane Database Syst Rev; 2013 Nov; (11):CD010551. PubMed ID: 24259154
[TBL] [Abstract][Full Text] [Related]
15. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of duloxetine and innovative pelvic floor muscle training in women with stress urinary incontinence (DULOXING): Study protocol clinical trial (SPIRIT Compliant).
Hagovska M; Svihra J
Medicine (Baltimore); 2020 Feb; 99(6):e18834. PubMed ID: 32028393
[TBL] [Abstract][Full Text] [Related]
17. Influence of voluntary pelvic floor muscle contraction and pelvic floor muscle training on urethral closure pressures: a systematic literature review.
Zubieta M; Carr RL; Drake MJ; Bø K
Int Urogynecol J; 2016 May; 27(5):687-96. PubMed ID: 26407561
[TBL] [Abstract][Full Text] [Related]
18. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat.
Thor KB; Katofiasc MA
J Pharmacol Exp Ther; 1995 Aug; 274(2):1014-24. PubMed ID: 7636716
[TBL] [Abstract][Full Text] [Related]
19. Effects of Duloxetine on Urethral Continence Reflex and Bladder Activity in Rats with Cerebral Infarction.
Miyazato M; Kitta T; Kaiho Y; Oshiro T; Saito S; Chancellor MB; de Groat WC; Yoshimura N
J Urol; 2015 Sep; 194(3):842-7. PubMed ID: 25804088
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatment of stress urinary incontinence: expectations for outcome.
Schuessler B; Baessler K
Urology; 2003 Oct; 62(4 Suppl 1):31-8. PubMed ID: 14550835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
